Industry news focusing on the people and organizations who work in the clinical trials profession.
• Catalent Pharma Solutions (Somerset, NJ) has made two new additions to its team with the appointments of Lois Johnson as Vice President of Quality, Development, and Clinical Services, and Alex Eslava as Vice President of Quality, Sterile Technologies.
Lois Johnson
• Bringing with him more than 13 years of pharmaceutical, commercial, and risk management experience, Frank Gallo was appointed Executive Director of Risk Management by PPD (Wilmington, NC).
• A QPS (Newark, DE) employee since 2002, Eric G. Solon, PhD, has a new role as Fellow, Autoradiography DMPK.
• Using her 13 years of quality assurance experience, Rose Buot will be Clearstone Central Laboratories' (Toronto, Canada) new Vice President of Global Quality Assurance.
Rose Buot
• CNS Network (Los Angeles, CA) has formed a partnership with Logos Technologies (Arlington, VA) to use Logos' early phase, e-source data capture system and site automation tools, ALPHADAS.
• Hitachi (Tokyo, Japan) and NextDocs (King of Prussia, PA) have formed an agreement in document management solutions for pharmaceutical manufacturers.
• By forming a strategic partnership with endpoint (San Francisco, CA), which develops Interactive Response Technology (IVR/IWR) platforms, Chiltern (London, UK) becomes a minority shareholder in the company.
Frank Gallo
• To facilitate the development of promising therapeutic medicines, Eli Lilly (Indianapolis, IN) has joined SNM's (Reston, VA) Clinical Trials Network.
• In order to accelerate development of a new class of antibiotics targeting drug-resistant "superbugs," Phico Therapeutics (Cambridge, UK) has raised a further €1.8 million.
• Aureus Pharma (Paris, France) is participating in a €118.2 million project, the Biointelligence R&D program, designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.
• Integrated Clinical Trial Services (Cary, NC) has launched a blog about patient recruitment and retention tips, enrollment issues, and the importance of site support at http://www.icts.us/blog.
• Enabling BioClinica (Newtown, PA) with clinical trial management software with Microsoft Office interoperability is its recent acquisition of TranSenda International (Bellevue, WA).
• Expanding its health outcomes measurement capabilities, Ingenix (Eden Prairie, MN) acquired QualityMetric Incorporated (Lincoln, RI).
Eric G. Solon, PhD
• Celerion (Lincoln, NE) completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services located in Lincoln, NE; Neptune, NJ; Phoenix, AZ; Richmond, VA; Quebec, Canada; Zurich, Switzerland; and Belfast, Northern Ireland.
• Expanding its facilities, Quintiles (Research Triangle Park, NC) has relocated its Global Central Laboratory in Japan from Saitama to Tokyo.
• Clearstone Central Laboratories (Toronto, Canada) is expanding its Toronto laboratory, increasing safety and esoteric testing capacities and capabilities.
• Nominations are now being accepted for the Regulatory Affairs Awards until May 24, 2010. To nominate your colleague or team, visit www.regulatoryaffairsawards.org. Email awards@topra.org or call +44 (0) 20 7510 2560 for more information. Awards will be presented at the Gala Dinner at the 2010 Annual Symposium on October 5, 2010.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.